In breast cancer, a number of plasma biomarkers, such as vascular endothelial growth factor (VEGF) and carcinoembryonic antigens, CA 15.3 and CA 27.59, were found to have a prognostic value [7]. This evidence concerns the gene VEGFA and breast carcinoma.